Site-directed mutation in a conserved kinase domain of human cytomegalovirus-pp65 with preservation of cytotoxic T lymphocyte targeting

Vaccine

Volumn 19, Issue 13-14, 2001, Pages 1628-1635

  Yao, Zhi Qiang ^a   Gallez Hawkins, Ghislaine ^a   Lomeli, Norma A ^a   Li, Xiuli ^a   Molinder, Karen M ^a   Diamond, Don J ^a   Zaia, John A ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

CMVpp65; Cytomegalovirus; Protein kinase; Vaccine

Indexed keywords

MUTANT PROTEIN; PROTEIN KINASE; VIRUS PROTEIN; VIRUS VACCINE;

AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME ACTIVITY; HUMAN CYTOMEGALOVIRUS; NONHUMAN; PHOSPHATE TRANSPORT; POINT MUTATION; PRIORITY JOURNAL; PROTEIN TARGETING;

AMINO ACID SEQUENCE; ANTIGENS, VIRAL; BLOTTING, WESTERN; CASEINS; CATALYTIC DOMAIN; CELL LINE; CHROMIUM; CONSERVED SEQUENCE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS VACCINES; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; HLA-A2 ANTIGEN; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTATION; PHOSPHOPROTEINS; PHOSPHORYLATION; PHOSPHOTHREONINE; PROTEIN KINASES; PROTEIN STRUCTURE, TERTIARY; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, SYNTHETIC; VACCINIA VIRUS; VIRAL MATRIX PROTEINS;

EID: 0035825604     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00423-0     Document Type: Article

References (47)

1. Altered natural history of AIDS-related opportunistic infections in the era of potent combination antiretroviral therapy
2. Cytomegalovirus infection in pregnancy
3. Cytomegalovirus Infection
4. Congenital cytomegalovirus infection
5. Immunization strategy for prevention of congenital cytomegalovirus infection
6. Human cytomegalovirus-specific cytotoxic T-cells: Relative frequency of stage-specific CTL recognizing the 72KD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses
7. Recognition of human cytomegalovirus gene products by HCMV-specific cytotoxic T-cells
8. In vitro cellular response to the late 64K glycoprotein of cytomegalovirus: Evidence for T-cell activation
9. Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T-lymphocytes
10. Class I MHC restricted cytotoxic T-lymphocyte recognition of cells infected with human cytomegalovirus does not require endogenous viral gene expression
11. The human CTL response to cytomegalovirus is dominated by structural protein pp65: Frequency, specificity, and T cell receptor usage of pp65specific CTL
12. Human cytomegalovirus virion-associated protein with kinase activity
13. Properties of a human cytomegalovirus-induced protein kinase
14. Genomic location of a human cytomegalovirus protein with protein kinase activity (PK68)
15. Induction of human cytomegalovirus (HCMV)-glycoprotein B (gB)-specific neutralizing antibody and phosphoprotein 65 (pp65)-specific cytotoxic T lymphocyte responses by naked DNA immunization
16. Direct DNA immunization of mice with plasmid DNA encoding the tegument protein pp65 of human cytomegalovirus induces high levels of circulating antibody to the encoded protein
17. Origins of G1 arrest in senescent human fibroblasts
18. Protein kinase catalytic domain sequence database: Identification of conserved features of primary structure and classification of family members
19. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD 169
20. The protein kinase family: Conserved features and deduced phylogeny of the catalytic domains
21. Identification of protein kinases by computer
22. Expression of proteins in mammalian cells using vaccinia virus vectors
23. Catalytic properties of a human cytomegalovirus-induced protein kinase
24. Enzyme activity dot blots for assaying protein kinases
25. Analysis of protein kinase substrate specificity by the use of peptide libraries on cellulose paper (SPOT-method)
26. Characterization of phosphoproteins and protein kinase activity of virions, noninfectious enveloped particles, and dense bodies of human cytomegalovirus
27. Nonradioactive assays of proteintyrosine kinase activity using anti-phosphotyrosine antibodies
28. Development of a candidate HLA A*0201 restricted peptide-based vaccine against human cytomegalovirus infection
29. Polo-like kinase 1 as a target for human cytomegalovirus pp65 lower matrix protein
30. Structural analysis of a 64-kDa major structural protein of human cytomegalovirus (Towne): Identification of a phosphorylation site and comparison to pp65 of HCMV (AD169)
31. Cytomegalovirus selectively blocks antigen processing and presentation of its immediate-early gene product
32. The role of protein phosphorylation in the hormonal control of enzyme activity
33. Protein serine/threonine kinases
34. Protein-tyrosine kinases
35. Alpha herpesvirus possess a gene homologous to the protein kinase gene family of eukaryotes and retroviruses
36. The dominant phosphoprotein pp65 (UL83) of human cytomegalovirus is dispensable for growth in cell culture
37. Human cytomegalovirus pp65 lower matrix phosphoprotein harbours two transplantable nuclear localization signals
38. Nuclear targeting of the tegument protein pp65 (UL83) of human cytomegalovirus: An unusual bipartite nuclear localization signal functions with other portions of the protein to mediate its efficient nuclear transport
39. Expression of human cytomegalovirus ppUL83 inhibits viral replication
40. Localization of human cytomegalovirus structural proteins to the nuclear matrix of infected human fibroblasts
41. Neither arginine, nor histidine can carry out the function of lysine-295 in the ATP-binding site of p60src
42. Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects on insulin
43. Lysine residue 121 in the proposed ATP-binding site of the v-mos protein is required for transformation
44. Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing
45. gag-fps in essential for protein-tyrosine kinase activity
46. Quantitation of human cytomegalovirus DNA in lungs from bone marrow transplant recipients with interstitial pneumonia
47. Human antibody reactivity against the lower matrix protein (pp65) produced by cytomegalovirus